Oruka Therapeutics SVP Finance Arjun Agarwal reports disposal of USD 800,089 in common shares
Bitget2026/10/13 20:34- Oruka Therapeutics SVP, Finance Arjun Agarwal exercised employee stock options on Oct. 12, 2026 for 9,999 shares.
- Exercise prices were $12.50 for 8,541 shares, $34.39 for 1,458 shares.
- He sold 9,999 shares the same day at weighted average prices of $80.0302, $80.7601, $81.8551, $82.835.
- Beneficial ownership ended at 14,219 common shares.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
U.S. stock futures fluctuate by $650 billions due to news related to Jensen Huang
Nikkei Average Index gains expand to 2.78%
Surprise! Japan intervened in the forex market three times this summer, selling a record 154 trillion yen in three days
Japan has confirmed that it intervened in the foreign exchange market three times this summer, buying yen to support the exchange rate, corroborating earlier market reports. This included the first joint intervention with the United States to support the yen in nearly thirty years.
UBS CEO warns: A Democratic sweep could slow down AI capacity building, valuation concerns are "very important"
UBS CEO Ermotti stated that the U.S. midterm elections may slow down AI capacity building and that the valuations are questionable; he also warned of persistent inflation and the risk of contagion in the European bond market.
Crypto prices
More
